Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
7.08
+0.02 (0.28%)
Jun 18, 2026, 4:00 PM EDT - Market closed
Armata Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4.75 | 8.69 | 9.29 | 13.52 | 14.85 | 10.29 |
Cash & Short-Term Investments | 4.75 | 8.69 | 9.29 | 13.52 | 14.85 | 10.29 |
Cash Growth | -59.33% | -6.49% | -31.30% | -8.95% | 44.36% | 6.62% |
Other Receivables | 0.05 | 0.47 | 0.74 | 3.36 | 8.53 | 2.99 |
Total Trade Receivables | 0.05 | 0.47 | 0.74 | 3.36 | 8.53 | 2.99 |
Other Current Assets | 1.15 | 1.51 | 1.27 | 2.27 | 3.66 | 1.72 |
Total Current Assets | 5.95 | 10.67 | 11.31 | 19.15 | 27.05 | 15 |
Net Property, Plant & Equipment | 33.4 | 33.91 | 41.69 | 57.28 | 46.65 | 38.07 |
Other Intangible Assets | 10.26 | 10.26 | 10.26 | 10.26 | 10.26 | 10.26 |
Goodwill | 3.49 | 3.49 | 3.49 | 3.49 | 3.49 | 3.49 |
Other Long-Term Assets | 4.93 | 6.36 | 6.46 | 8.19 | 8.39 | 2.96 |
Total Assets | 69.8 | 76.88 | 86.44 | 98.36 | 95.83 | 69.77 |
Accounts Payable | 1.45 | 1.71 | 2.06 | 5.69 | 6.03 | 2.27 |
Accrued Expenses | 2.82 | 2.19 | 2.28 | 0.77 | 1.83 | 1.04 |
Short-Term Debt | - | - | 38.95 | - | - | - |
Current Portion of Leases | 4.59 | 4.56 | 4.43 | 9.48 | 17.01 | 1.51 |
Other Current Liabilities | 0.37 | 0.49 | 0.53 | 0.52 | - | - |
Total Current Liabilities | 9.23 | 8.95 | 48.25 | 16.46 | 24.87 | 4.81 |
Long-Term Debt | 342.9 | 256.92 | 55.44 | 82.31 | - | - |
Long-Term Leases | 26.18 | 26.53 | 27.69 | 28.58 | 31.8 | 36.48 |
Other Long-Term Liabilities | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 |
Total Long-Term Liabilities | 372.16 | 286.53 | 86.21 | 113.97 | 34.88 | 39.56 |
Total Liabilities | 381.39 | 295.48 | 134.46 | 130.43 | 59.75 | 44.37 |
Common Stock | 0.37 | 0.36 | 0.36 | 0.36 | 0.36 | 0.27 |
Additional Paid-in Capital | 304.93 | 282.57 | 279.35 | 276.39 | 275.49 | 227.98 |
Retained Earnings | -616.88 | -501.53 | -327.74 | -308.82 | -239.77 | -202.86 |
Shareholders' Equity | -311.59 | -218.6 | -48.02 | -32.07 | 36.08 | 25.4 |
Total Liabilities & Equity | 69.8 | 76.88 | 86.44 | 98.36 | 95.83 | 69.77 |
Total Debt | 373.67 | 288.02 | 126.52 | 120.37 | 48.82 | 37.99 |
Net Cash (Debt) | -368.92 | -279.33 | -117.22 | -106.85 | -33.96 | -27.7 |
Net Cash Per Share | -10.16 | -7.71 | -3.24 | -2.96 | -0.99 | -1.15 |
Book Value | -311.59 | -218.6 | -48.02 | -32.07 | 36.08 | 25.4 |
Book Value Per Share | -8.58 | -6.03 | -1.33 | -0.89 | 1.05 | 1.05 |
Tangible Book Value | -325.33 | -232.34 | -61.77 | -45.81 | 22.33 | 11.65 |
Tangible Book Value Per Share | -8.96 | -6.41 | -1.71 | -1.27 | 0.65 | 0.48 |